<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T04:15:20Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/33603" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/33603</identifier><datestamp>2026-09-26T07:06:38Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Rheinstadter, Maikel</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Krivic, Hannah</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department">Physics and Astronomy</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2026-09-25T15:01:08Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2026</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/11375/33603</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/25374</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Drug administration is limited by random distribution, rapid degradation, drug toxicity, and inaccessibility to target sites. Nanocarriers have been developed to address these issues by localizing drug delivery and reducing off-target interactions. Synthetic liposomes are commonly used but often fail clinically due to immune clearance and physical instability leading to premature cargo release. Recent drug delivery has focused on utilizing biomimetic carriers to address these limitations. Erythrocytes, in particular, are promising due to their naturally long circulation, inherent immune protection, and strong mechanical stability. Cargo can be loaded in the erythrocyte interior or attached to the surface. Moreover, the erythrocyte membrane itself can be used as the nanocarrier. 

This thesis investigates erythrocyte liposomes for targeted drug delivery, focusing on carrier optimization. Electrostatic interactions drove the loading of cationic cargo by doping the erythrocyte membranes with anionic lipids to produce hybrid erythrocyte liposomes. Molecular dynamics simulations revealed that cargo loading depends on the extent of membrane doping, the number of cargo molecules per liposome, and cargo stability upon membrane contact.

Antibiotic resistance is a global major concern, creating the urgent need for new therapies. The first application targeted the delivery of polymyxin B to E.coli using hybrid erythrocyte liposomes functionalized with anti-E.coli antibodies. The formulation displayed an efficacy comparable to that of the free drug against E.coli, with high specificity and minimal toxicity.

Brain-derived neurotrophic factor (BDNF) is a protein that is essential for neuronal differentiation, neuroprotection, learning, and memory. It has been shown to be downregulated in many neurodegenerative diseases and psychiatric conditions. Although treatment with BDNF is shown to improve symptoms associated with these conditions, its delivery to the brain is limited by the blood-brain barrier. Erythrocyte liposomes were engineered with antibodies to exploit the transferrin receptor-mediated transport pathway and deliver BDNF into the brain. Mice exhibiting the pathology for Alzheimer's disease were treated with the formulation and exhibited improvements in spatial learning and memory.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en</dim:field>
   <dim:field mdschema="dc" element="subject">Membranes</dim:field>
   <dim:field mdschema="dc" element="subject">Blood</dim:field>
   <dim:field mdschema="dc" element="subject">Red Blood Cells</dim:field>
   <dim:field mdschema="dc" element="subject">Drug Delivery</dim:field>
   <dim:field mdschema="dc" element="subject">Liposomes</dim:field>
   <dim:field mdschema="dc" element="subject">Functionalized Membranes</dim:field>
   <dim:field mdschema="dc" element="title">Manipulation and Functionalization of Erythrocyte Membranes</dim:field>
   <dim:field mdschema="dc" element="type">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">embargo</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>